Dexamethasone intravitreal implant
Dexamethasone intravitreal implant is a pharmaceutical drug with 23 clinical trials. Currently 2 active trials ongoing. Historical success rate of 89.5%.
Success Metrics
Based on 17 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
4
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
89.5%
17 of 19 finished
10.5%
2 ended early
2
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema
EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
OCTA in Epivascular Glia After Dex Implant
Clinical Trials (23)
Dexamethasone Implant for Retinal Detachment in Uveal Melanoma
Medico Economic Evaluation of Fluocinolone Acetonide Implant Versus Dexametheasone Implant in Resistant Diabetic Macular Oedema
EC-104 Intravitreal Implant for the Treatment of Diabetic Macular Edema
Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation
OCTA in Epivascular Glia After Dex Implant
A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
Intravitreal Dexamethasone vs Bevacizumab in Aboriginal People With DMO
Chart Review: Drug Utilization Study in Participants Who Received Ozurdex™ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME)
Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion
A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema
Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema
Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study
PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial
Phase II Combination Steroid and Anti-VEGF for Persistent DME
A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus
Dexamethasone Intravitreal Implant After Vitrectomy For Epiretinal Membrane
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 23